Table 2 Association between compliance at 30 weeks and baseline conditionsa
Variable | 30-week Weight available | P value | 30-week Cholesterol available | P value | ||
|---|---|---|---|---|---|---|
Yes (N = 243) | No N = (186) | Yes (N = 295) | No (N = 128) | |||
Baseline conditions: | ||||||
Diabetes N (%) | 176 (72) | 133 (72) | 0.97 | 220 (75) | 88 (69) | 0.26 |
Obesity (BMI> 30) N (%) N (%) | 185 (76) | 160 (95) | 0.011b | 232 (79) | 108 (84) | 0.17 |
Hyperlipidemia N (%) | 151 (62) | 104 (56) | 0.19 | 185 (63) | 68 (53) | 0.065 |
Hypertension N (%) | 155 (64) | 115 (62) | 0.68 | 193 (65) | 73 (57) | 0.10 |
Metabolic syndrome N (%) | 135 (56) | 112 (61) | 0.33 | 175 (60) | 71 (56) | 0.47 |
Biometrics at week 6: | ||||||
Weight (kg) | 95 ± 22 | 105 ± 26 | < 0.001b | 96 ± 22 | 105 ± 26 | 0.002b |
Waist (cm) | 107 ± 15 | 112 ± 17 | 0.002b | 108 ± 15 | 112 ± 18 | 0.046b |
Body mass index (kg/m2) | 34 ± 7 | 37 ± 8 | < 0.001b | 34 ± 7 | 37 ± 8 | 0.004b |
Systolic blood pressure (mmHg) | 126 ± 13 | 127 ± 15 | 0.66 | 126 ± 13 | 127 ± 15 | 0.69 |
Diastolic blood pressure (mmHg) | 79 ± 8 | 79 ± 9 | 0.78 | 79 ± 8 | 79 ± 9 | 0.90 |
Heart rate (bpm) | 71 ± 11 | 73 ± 12 | 0.056 | 71 ± 11 | 74 ± 12 | 0.014b |
Metabolic variables at week 6: | ||||||
Glucose (mg/dL) | 101 ± 25 | 104 ± 27 | 0.32 | 101 ± 24 | 104 ± 30 | 0.40 |
(mmol/L) | 5.6 ± 1.4 | 5.8 ± 1.5 | 5.6 ± 1.3 | 5.8 ± 1.7 | ||
Triglycerides (mg/dL) | 102 ± 49 | 115 ± 54 | 0.02b | 103 ± 49 | 118 ± 57 | 0.023b |
(mmol/L) | 1.2 ± 0.6 | 1.3 ± 0.6 | 1.2 ± 0.6 | 1.3 ± 0.6 | ||
Cholesterol (mg/dL) | 164 ± 35 | 170 ± 38 | 0.11 | 164 ± 36 | 171 ± 37 | 0.08 |
(mmol/L) | 4.2 ± 0.9 | 4.4 ± 1.0 | 4.2 ± 0.9 | 4.4 ± 1.0 | ||
High-density lipoprotein (mg/dL) | 51 ± 15 | 48 ± 13 | 0.08 | 50 ± 14 | 49 ± 15 | 0.33 |
Cholesterol (mmol/L) | 1.3 ± 0.4 | 1.2 ± 0.3 | 1.3 ± 0.4 | 1.3 ± 0.4 | ||
Low-density lipoprotein (mg/dL) | 92 ± 29 | 99 ± 34 | 0.06 | 93 ± 30 | 99 ± 33 | 0.11 |
Cholesterol (mmol/L) | 2.4 ± 0.7 | 2.6 ± 0.9 | 2.4 ± 0.8 | 2.6 ± 0.9 | ||
Change in biometrics from baseline to six weeks: | ||||||
Weight (kg) | -4.0 ± 2.5 | -3.6 ± 2.8 | 0.16 | -4.1 ± 2.6 | -3.1 ± 2.7 | < 0.001b |
Waist (cm) | -4.0 ± 4.1 | -4.4 ± 4.2 | 0.36 | -4.2 ± 4.1 | -4.0 ± 4.4 | 0.66 |
Body mass index (kg/m2) | -1.4 ± 0.9 | -1.3 ± 1.0 | 0.12 | -1.5 ± 0.9 | -1.1 ± 0.9 | < 0.001b |
Systolic blood pressure (mmHg) | -5.1 ± 15.7 | -5.1 ± 15.2 | 0.98 | -5.8 ± 15.1 | -3.7 ± 16.6 | 0.24 |
Diastolic blood pressure (mmHg) | -2.7 ± 8.6 | -3.9 ± 10.9 | 0.24 | -3.1 ± 9.2 | -3.5 ± 10.7 | 0.75 |
Heart rate (bpm) | -4.7 ± 1.7 | -6.2 ± 11.2 | 0.20 | -5.4 ± 10.9 | -5.3 ± 12.8 | 0.92 |
Change in metabolic variables from baseline to six weeks: | ||||||
Glucose (mg/dL) | -6 ± 24 | -6 ± 25 | 0.96 | -6 ± 22 | -7 ± 29 | 0.67 |
(mmol/L) | -0.3 ± 1.3 | -0.3 ± 1.4 | -0.3 ± 1.2 | -0.4 ± 1.6 | ||
Triglycerides (mg/dL) | -31 ± 55 | -23 ± 51 | 0.12 | -32 ± 55 | -17 ± 49 | 0.010b |
(mmol/L) | -0.4 ± 0.6 | -0.3 ± 0.6 | -0.4 ± 0.6 | -0.2 ± 0.6 | ||
Cholesterol (mg/dL) | -25 ± 26 | -17 ± 25 | < 0.001b | -24 ± 28 | -14 ± 19 | < 0.001b |
(mmol/L) | -0.7 ± 0.7 | -0.4 ± 0.6 | -0.6 ± 0.7 | -0.4 ± 0.5 | ||
High-density lipoprotein (mg/dL) | -2.3 ± 7 | -1.7 ± 6 | 0.37 | -1.9 ± 7.0 | -2.4 ± 6.0 | 0.50 |
Cholesterol (mmol/L) | -0.1 ± 0.2 | -0.0 ± 0.2 | -0.0 ± 0.2 | -0.1 ± 0.2 | ||
Low-density lipoprotein (mg/dL) | -17 ± 21 | -10 ± 21 | < 0.001b | -17 ± 22 | -8 ± 19 | < 0.001b |
Cholesterol (mmol/L) | -0.5 ± 0.6 | -0.3 ± 0.5 | -0.4 ± 0.6 | -0.2 ± 0.5 | ||